retatrutide clinical trial results 2024 2025 press release Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports Retatrutide Where to Get: Can

The mean weight loss among participants in its phase 1 trial was 13 percent of their starting body weight after 12 weeks

The BMI and health-condition criteria include: BMI of 35 or higher BMI of 30 or higher with certain conditions, such as heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease stage 3a or above BMI of 27 or higher with certain conditions, such as prediabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease If you live near HCA Florida Lawnwood Hospital in the Port St

Talk to your GP, or check your eligibility for evidence-based options through our [weight loss medication UK guide](/blog/weight-loss-medication-uk)

63: S39-S62

aureus or E

December 31, 2025